Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 62.34M | 60.14M | 63.72M | 65.13M | 60.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.34M | 60.14M | 63.72M | 65.13M | 60.74M |
| Cost of Revenue | 22.46M | 21.13M | 21.52M | 23.33M | 23.41M |
| Gross Profit | 39.88M | 39.01M | 42.21M | 41.80M | 37.33M |
| SG&A Expenses | 26.44M | 27.26M | 34.21M | 28.79M | 27.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.95M | 53.11M | 60.98M | 57.15M | 56.01M |
| Operating Income | 8.39M | 7.03M | 2.75M | 7.98M | 4.72M |
| Income Before Tax | 6.03M | 4.35M | -1.59M | 4.60M | 2.00M |
| Income Tax Expenses | 1.69M | 1.52M | 2.54M | 966.00K | -477.00K |
| Earnings from Continuing Operations | 4.34M | 2.83M | -4.14M | 3.63M | 2.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.34M | 2.83M | -4.14M | 3.63M | 2.48M |
| EBIT | 8.39M | 7.03M | 2.75M | 7.98M | 4.72M |
| EBITDA | 13.95M | 12.68M | 8.50M | 13.69M | 10.57M |
| EPS Basic | 0.77 | 0.50 | -0.75 | 0.66 | 0.45 |
| Normalized Basic EPS | 0.67 | 0.48 | -0.18 | 0.52 | 0.23 |
| EPS Diluted | 0.75 | 0.49 | -0.75 | 0.65 | 0.45 |
| Normalized Diluted EPS | 0.65 | 0.47 | -0.18 | 0.52 | 0.23 |
| Average Basic Shares Outstanding | 5.64M | 5.66M | 5.54M | 5.53M | 5.51M |
| Average Diluted Shares Outstanding | 5.76M | 5.76M | 5.54M | 5.57M | 5.54M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | 20.69% | 31.24% | -21.37% | 24.35% | 35.62% |